BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6696817)

  • 1. Immunological detection of faecal occult blood in colorectal cancer.
    Turunen MJ; Liewendahl K; Partanen P; Adlercreutz H
    Br J Cancer; 1984 Feb; 49(2):141-8. PubMed ID: 6696817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo.
    Adlercreutz H; Partanen P; Virkola P; Liewendahl K; Turunen MJ
    Scand J Clin Lab Invest; 1984 Oct; 44(6):519-28. PubMed ID: 6333067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
    Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
    Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of occult blood tests over a six-day period.
    Farrands PA; Hardcastle JD
    Clin Oncol; 1983 Sep; 9(3):217-25. PubMed ID: 6616996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of Fecatwin/Feca EIA; a faecal occult blood test for detecting colonic neoplasia.
    Pye G; Marks CG; Martin S; Marks V; Jackson J; Hardcastle JD
    Eur J Surg Oncol; 1989 Oct; 15(5):446-8. PubMed ID: 2792395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy.
    Dybdahl JH; Daae LN; Larsen S; Myren J
    Scand J Gastroenterol; 1984 Mar; 19(2):245-54. PubMed ID: 6609422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology.
    Stelling HP; Maimon HN; Smith RA; Haddy RI; Markert RJ
    Arch Intern Med; 1990 May; 150(5):1001-5. PubMed ID: 2331181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal occult blood testing in symptomatic patients: comparison of three tests.
    Tate JJ; Northway J; Royle GT; Taylor I
    Br J Surg; 1990 May; 77(5):523-6. PubMed ID: 2354334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
    Trojan J; Povse N; Schröder O; Stein J
    Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of Haemoccult and Fecatwin in the detection of colorectal neoplasia in hospital and general practice patients.
    Barrison IG; Parkins RA
    Postgrad Med J; 1985 Aug; 61(718):701-4. PubMed ID: 4034460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological detection of occult blood in bowel cancer patients.
    Kapparis A; Frommer D
    Br J Cancer; 1985 Dec; 52(6):857-61. PubMed ID: 3935151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding colorectal tumours with an immunological faecal occult blood test in symptomatic primary health care patients.
    Kemppainen M; Häkkinen I; Räihä I; Pomoell R; Sourander L
    Age Ageing; 1994 Sep; 23(5):365-70. PubMed ID: 7825480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with haemoccult screening in Hungary. A multicenter trial.
    Siba S
    Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the new immunological test Hemoblot for detecting occult blood in faeces.
    Jeanson A; Jamart J; Maisin JM; Vanheuverzwyn R; Gohy P; Debongnie JC; Rentier B
    Eur J Cancer Prev; 1994 Sep; 3(5):407-12. PubMed ID: 8000309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
    Br J Cancer; 2009 Apr; 100(8):1230-5. PubMed ID: 19337253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer.
    Hall C; Griffin J; Dykes PW; Williams JA; Keighley MR
    Gut; 1993 Feb; 34(2):227-9. PubMed ID: 8432478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for symptomless colorectal cancer by testing for occult blood in general practice.
    Hardcastle JD; Balfour TW; Amar SS
    Lancet; 1980 Apr; 1(8172):791-3. PubMed ID: 6102678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New screening method for occult gastrointestinal bleeding: immunologic and guaiac slide tests.
    Stelling HP; Maimon H; Smith RA; Bigley NJ; Mukherjee MD
    J Fam Pract; 1984 Dec; 19(6):757-61. PubMed ID: 6438268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
    Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
    Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.